These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 12004142)

  • 1. [Efficacy of specific immunotherapy in children with seasonal allergic rhinitis and conjunctivitis, sensitized to grass pollen].
    Bulawa E; Borysewicz G; Markiewicz K; Derentowicz P
    Med Wieku Rozwoj; 2001; 5(4):351-8. PubMed ID: 12004142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen.
    Wüthrich B; Bucher Ch; Jörg W; Bircher A; Eng P; Schneider Y; Schnyder F; Eigenmann P; Senti G
    J Investig Allergol Clin Immunol; 2003; 13(3):145-8. PubMed ID: 14635462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.
    Didier A; Malling HJ; Worm M; Horak F; Jäger S; Montagut A; André C; de Beaumont O; Melac M
    J Allergy Clin Immunol; 2007 Dec; 120(6):1338-45. PubMed ID: 17935764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive symptomatic immunotherapy versus placebo in seasonal rhinitis due to grasses in children and to Parietaria in adult patients.
    Troise C; Bignardi D; Modena P; Pissacroia C; Di Berardino F
    Allerg Immunol (Paris); 2000 Jun; 32(6):246-9. PubMed ID: 10971859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular sensitization patterns and influence of molecular diagnosis in immunotherapy prescription in children sensitized to both grass and olive pollen.
    Martínez-Cañavate Burgos A; Torres-Borrego J; Molina Terán AB; Corzo JL; García BE; Rodríguez Pacheco R; Moreno Aguilar C; Dávila I
    Pediatr Allergy Immunol; 2018 Jun; 29(4):369-374. PubMed ID: 29369414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
    Hordijk GJ; Antvelink JB; Luwema RA
    Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma.
    Murphy K; Gawchik S; Bernstein D; Andersen J; Pedersen MR
    J Negat Results Biomed; 2013 Jun; 12():10. PubMed ID: 23725348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sublingual specific immunotherapy for rhinoconjunctivitis caused by grass pollens].
    Sabbah A; Lesellin J; Hassoun S; Sicard H; André C
    Allerg Immunol (Paris); 1993 Jun; 25(6):241-7. PubMed ID: 8357473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.
    Rolinck-Werninghaus C; Wolf H; Liebke C; Baars JC; Lange J; Kopp MV; Hammermann J; Leupold W; Bartels P; Gruebl A; Bauer CP; Schnitker J; Wahn U; Niggemann B
    Allergy; 2004 Dec; 59(12):1285-93. PubMed ID: 15507097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which allergen extract for grass pollen immunotherapy? An in vitro study.
    Marcucci F; Sensi L; Di Cara G; Incorvaia C; Puccinelli P; Scurati S; Frati F
    Immunol Invest; 2010; 39(6):635-44. PubMed ID: 20653430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pollen-induced allergic rhinitis in 1360 Italian children: comorbidities and determinants of severity.
    Dondi A; Tripodi S; Panetta V; Asero R; Businco AD; Bianchi A; Carlucci A; Ricci G; Bellini F; Maiello N; del Giudice MM; Frediani T; Sodano S; Dello Iacono I; Macrì F; Massaccesi V; Caffarelli C; Rinaldi L; Patria MF; Varin E; Peroni D; Chinellato I; Chini L; Moschese V; Lucarelli S; Bernardini R; Pingitore G; Pelosi U; Tosca M; Paravati F; La Grutta S; Meglio P; Calvani M; Plebani M; Matricardi PM;
    Pediatr Allergy Immunol; 2013 Dec; 24(8):742-51. PubMed ID: 24236692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oralair®: sublingual immunotherapy for the treatment of grass pollen allergic rhinoconjunctivitis.
    Hong J; Bielory L
    Expert Rev Clin Immunol; 2011 Jul; 7(4):437-44. PubMed ID: 21790286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of allergen immunotherapy and drug treatment in seasonal rhinoconjunctivitis: a 3-years study.
    Giovannini M; Braccioni F; Sella G; Contoli M; Perri G; Frati F; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):69-71. PubMed ID: 15859367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
    Valovirta E; Jacobsen L; Ljørring C; Koivikko A; Savolainen J
    Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of preseasonal grass pollen immunotherapy in children.
    Eng PA; Reinhold M; Gnehm HP
    Allergy; 2002 Apr; 57(4):306-12. PubMed ID: 11906360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.
    Bufe A; Eberle P; Franke-Beckmann E; Funck J; Kimmig M; Klimek L; Knecht R; Stephan V; Tholstrup B; Weisshaar C; Kaiser F
    J Allergy Clin Immunol; 2009 Jan; 123(1):167-173.e7. PubMed ID: 19130937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.